Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Mindfulness-Based Therapy for Chronic Low Back Pain in Office Workers

29 de mayo de 2026 actualizado por: Merve Sevindi İmançer, Dokuz Eylul University

The Effect of Mindfulness-Based Therapies on Pain Severity in Office Workers With Non-Specific Chronic Low Back Pain: A Randomized Controlled Trial

This study evaluated whether a mindfulness-based therapy program could reduce pain severity in office workers with non-specific chronic low back pain.

The study included staff members of Dokuz Eylul University aged 20 to 59 years who had low back pain for at least three months and worked at a desk for more than four hours per day. Participants were randomly assigned to either a mindfulness-based therapy group or a control group.

The mindfulness-based therapy group attended online group sessions once a week for four weeks. The sessions included breathing awareness meditation, body scan meditation, self-compassion meditation, and chair yoga practices. Participants in the control group continued their usual medical care during the study period.

The primary outcome of the study was pain severity, assessed using the Visual Analogue Scale. Secondary outcomes included physical activity level, disability related to low back pain, anxiety symptoms, quality of life, and mindfulness level.

Participants were evaluated at baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up).

Descripción general del estudio

Estado

Terminado

Condiciones

Intervención / Tratamiento

Tipo de estudio

Intervencionista

Inscripción (Actual)

104

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

  • Turquía (Türkiye)
    • Balçova
      • Izmir, Balçova, Turquía (Türkiye), 35340
        • Dokuz Eylul University

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • Staff member of Dokuz Eylül University
  • Aged between 20 and 59 years
  • Willing to participate in the study
  • Having low back pain for at least 3 months
  • Working at a desk for more than 4 hours per day
  • Having access to an internet connection at home or at work
  • Having a computer and/or smartphone suitable for participating in online sessions and completing online forms

Exclusion Criteria:

  • Presence of an organic condition that could explain low back pain, such as lumbar disc herniation
  • Presence of an underlying rheumatological disease, such as ankylosing spondylitis or rheumatoid arthritis
  • Diagnosed psychiatric disorder
  • Alcohol or substance dependence
  • Current use of psychiatric medication
  • Pregnancy
  • Speech or hearing problems that could interfere with participation

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Mindfulness-Based Therapy Group
Participants in this arm received a four-week online mindfulness-based therapy program. The program consisted of weekly 60-90-minute group sessions delivered online in small groups of approximately 8-10 participants. The sessions included breathing awareness meditation, body scan meditation, self-compassion meditation, and chair yoga practices. Participants were also encouraged to practise breathing awareness and body scan exercises at home for 10-15 minutes daily and to record their practice using a mindfulness practice log.
Conductual: Mindfulness-Based Therapy Program
The intervention was a four-week online mindfulness-based therapy program delivered in small groups of approximately 8-10 participants. Participants attended one 60-90-minute online group session per week. The program included breathing awareness meditation, body scan meditation, self-compassion meditation, and chair yoga practices adapted for office workers with non-specific chronic low back pain. Each session included a brief theoretical introduction, guided practice, participant reflection, and a question-and-answer section. Participants were encouraged to practise breathing awareness and body scan exercises at home for 10-15 minutes daily and to record their practice, thoughts, and emotions using a mindfulness practice log.
Sin intervención: Usual Care Control Group
Participants in this arm continued their usual medical care during the study period and did not receive the mindfulness-based therapy program during the active study phase. After completion of the six-month follow-up assessment, participants were provided with video and audio recordings and written materials introducing the mindfulness techniques used in the intervention group.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change From Baseline in Pain Severity on the Visual Analogue Scale
Periodo de tiempo: Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Pain severity was assessed using the Visual Analogue Scale (VAS), a 0-100 scale in which higher scores indicate greater pain severity.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change From Baseline in Physical Activity Level on the International Physical Activity Questionnaire Short Form
Periodo de tiempo: Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Physical activity level was assessed using the International Physical Activity Questionnaire Short Form (IPAQ-SF). The questionnaire assesses walking, moderate-intensity activity, vigorous-intensity activity, and sitting time during the previous 7 days. Physical activity is reported as metabolic equivalent task minutes per week (MET-min/week). Higher MET-min/week values indicate higher physical activity levels.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Change From Baseline in Low Back Pain-Related Disability on the Roland-Morris Disability Questionnaire
Periodo de tiempo: Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Low back pain-related functional disability was assessed using the Roland-Morris Disability Questionnaire (RMDQ). The questionnaire includes 24 items scored as 0 or 1, resulting in a total score ranging from 0 to 24. Higher scores indicate greater functional disability.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Change From Baseline in Health-Related Quality of Life on the Short Form-36 Health Survey
Periodo de tiempo: Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Health-related quality of life was assessed using the Short Form-36 Health Survey (SF-36). The SF-36 evaluates multiple domains of health-related quality of life. Domain scores range from 0 to 100, with higher scores indicating better health status.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Change From Baseline in Anxiety Symptoms on the Beck Anxiety Inventory
Periodo de tiempo: Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Anxiety symptoms were assessed using the Beck Anxiety Inventory (BAI). The scale includes 21 items, each scored from 0 to 3, resulting in a total score ranging from 0 to 63. Higher scores indicate greater anxiety symptom severity.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Change From Baseline in Mindfulness Level on the Five Facet Mindfulness Questionnaire Short Form
Periodo de tiempo: Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)
Mindfulness level was assessed using the Five Facet Mindfulness Questionnaire Short Form (FFMQ-SF). The questionnaire evaluates five facets of mindfulness: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Higher scores indicate higher mindfulness levels.
Baseline, Week 4 (end of intervention), Week 16 (3-month follow-up), and Week 28 (6-month follow-up)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Dokuz Eylul University

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

4 de abril de 2022

Finalización primaria (Actual)

6 de junio de 2022

Finalización del estudio (Actual)

23 de enero de 2023

Fechas de registro del estudio

Enviado por primera vez

24 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

29 de mayo de 2026

Publicado por primera vez (Actual)

2 de junio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

2 de junio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

29 de mayo de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • DEU-2021-27-08

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Descripción del plan IPD

No individual participant data will be shared. Only aggregate study results will be reported in publications and presentations.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir